Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9359 |
High Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.9295 |
High Similarity |
NPD1934 |
Approved |
0.8994 |
High Similarity |
NPD2801 |
Approved |
0.8963 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8963 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8963 |
High Similarity |
NPD6166 |
Phase 2 |
0.8805 |
High Similarity |
NPD4380 |
Phase 2 |
0.8802 |
High Similarity |
NPD5844 |
Phase 1 |
0.8802 |
High Similarity |
NPD7054 |
Approved |
0.8782 |
High Similarity |
NPD1511 |
Approved |
0.878 |
High Similarity |
NPD6959 |
Discontinued |
0.875 |
High Similarity |
NPD7472 |
Approved |
0.875 |
High Similarity |
NPD7074 |
Phase 3 |
0.8727 |
High Similarity |
NPD6232 |
Discontinued |
0.872 |
High Similarity |
NPD5494 |
Approved |
0.8683 |
High Similarity |
NPD7473 |
Discontinued |
0.8671 |
High Similarity |
NPD1512 |
Approved |
0.865 |
High Similarity |
NPD3882 |
Suspended |
0.8631 |
High Similarity |
NPD3818 |
Discontinued |
0.8608 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8589 |
High Similarity |
NPD3817 |
Phase 2 |
0.8588 |
High Similarity |
NPD6797 |
Phase 2 |
0.8538 |
High Similarity |
NPD7251 |
Discontinued |
0.8537 |
High Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8528 |
High Similarity |
NPD7819 |
Suspended |
0.8488 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8488 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.8485 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8485 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8476 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8415 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8397 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8375 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8363 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8303 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.8242 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8218 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8217 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8182 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.8153 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8148 |
Intermediate Similarity |
NPD2532 |
Approved |
0.8148 |
Intermediate Similarity |
NPD2534 |
Approved |
0.8148 |
Intermediate Similarity |
NPD2533 |
Approved |
0.8121 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8101 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.8057 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8025 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8012 |
Intermediate Similarity |
NPD3750 |
Approved |
0.8011 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7977 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7975 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7941 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7929 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7907 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7898 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7898 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7898 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7895 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7895 |
Intermediate Similarity |
NPD919 |
Approved |
0.7882 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7875 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7875 |
Intermediate Similarity |
NPD6099 |
Approved |
0.7866 |
Intermediate Similarity |
NPD7390 |
Discontinued |
0.7844 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7833 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7831 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7826 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7821 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7821 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7812 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7807 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7791 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7785 |
Intermediate Similarity |
NPD943 |
Approved |
0.7784 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7784 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7759 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7756 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.773 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7714 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7713 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7713 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7711 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7711 |
Intermediate Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.7707 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7707 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7706 |
Intermediate Similarity |
NPD37 |
Approved |
0.7702 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7701 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7692 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7692 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7674 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7674 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7674 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7657 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7657 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7654 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7654 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7633 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7622 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7614 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7593 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7592 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7577 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7576 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.7569 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.754 |
Intermediate Similarity |
NPD4360 |
Phase 2 |
0.754 |
Intermediate Similarity |
NPD4363 |
Phase 3 |
0.7516 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7515 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7515 |
Intermediate Similarity |
NPD920 |
Approved |
0.7514 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.75 |
Intermediate Similarity |
NPD7698 |
Approved |
0.75 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.75 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7471 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7461 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7461 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7448 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.7447 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7447 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7438 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7436 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7421 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.741 |
Intermediate Similarity |
NPD1243 |
Approved |
0.741 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.741 |
Intermediate Similarity |
NPD5698 |
Clinical (unspecified phase) |
0.7407 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7405 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7396 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7385 |
Intermediate Similarity |
NPD7584 |
Approved |
0.7381 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7378 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7368 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7363 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7362 |
Intermediate Similarity |
NPD6651 |
Approved |
0.736 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.736 |
Intermediate Similarity |
NPD7874 |
Approved |
0.7348 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7337 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5404 |
Approved |
0.733 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.733 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7329 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7326 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7323 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7322 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7321 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7306 |
Intermediate Similarity |
NPD2494 |
Approved |
0.7306 |
Intermediate Similarity |
NPD2493 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.7301 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7301 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.7289 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7273 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7263 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7262 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.725 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7239 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7222 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7216 |
Intermediate Similarity |
NPD3452 |
Approved |
0.7216 |
Intermediate Similarity |
NPD3450 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7215 |
Intermediate Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.7207 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7202 |
Intermediate Similarity |
NPD8285 |
Discontinued |
0.7198 |
Intermediate Similarity |
NPD7177 |
Discontinued |
0.7197 |
Intermediate Similarity |
NPD1201 |
Approved |
0.7197 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7197 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7194 |
Intermediate Similarity |
NPD4583 |
Approved |
0.7194 |
Intermediate Similarity |
NPD4582 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7194 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7171 |
Intermediate Similarity |
NPD7907 |
Approved |
0.7169 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.716 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7159 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7157 |
Intermediate Similarity |
NPD4665 |
Approved |
0.7157 |
Intermediate Similarity |
NPD4111 |
Phase 1 |
0.7151 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7143 |
Intermediate Similarity |
NPD4002 |
Approved |
0.7143 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD4004 |
Approved |
0.7143 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7135
|
Intermediate Similarity |
NPD4361 |
Phase 2 |